NASDAQ
22.43USD
-0.25 (-1.10%)
We have scored 5 news catalysts on Tactile Systems Technology, Inc. (TCMD) over the past 12 months. The biggest single-day move next to one of them came Feb 19, 2026, when TCMD closed −14.5%: “Why Tactile Systems Technology Stock Surged by Nearly 18% Today”. Coverage across the window leans positive (average ticker sentiment +0.78). Most of the impact sits in price momentum and revenue growth rate.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
505.9M
P/E
—
EPS
—
Beta
0.79
52W range
13.385-37.77
Day range
22.08–22.74
Open
22.59
Prev close
22.68
Volume
140.8K
Avg volume
291.3K
Dividend
0.00
IPO
2016-07-28
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Tactile Systems Technology, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for TCMD: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
